GLP-1 Coverage & Costs in Virginia (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Virginia at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Virginia Medicaid Coverage for GLP-1
Medicaid: covered as of January 2026 (KFF)
KFF's map lists Virginia among the 13 state programs covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Virginia Medicaid GLP-1 Prescriptions in 2025
227,472
#14
$221.5 million
Trulicity
Virginia Medicaid paid for 227,472 GLP-1 prescriptions in 2025, 2% of the 11.26 million paid nationally and number 14 of 51 (50 states and DC). It reimbursed pharmacies $221.5 million before manufacturer rebates, about $974 per prescription, and the most-filled product was Trulicity. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 44,787 of those prescriptions (19.7%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Virginia Medicaid GLP-1 prescriptions went from 65,943 to 227,472, 3.4 times the 2021 count. From 2024 to 2025 the count rose by 4,714.
65,943
126,918
198,985
222,758
227,472
| Product | VA Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Trulicity | 115,903 | 51% |
| Ozempic | 28,955 | 12.7% |
| Mounjaro | 27,595 | 12.1% |
| Wegovy | 24,209 | 10.6% |
| Zepbound | 11,795 | 5.2% |
| Saxenda | 8,783 | 3.9% |
| Liraglutide (generic) | 3,928 | 1.7% |
| Victoza | 3,609 | 1.6% |
| Rybelsus | 2,396 | 1.1% |
| Byetta | 178 | 0.1% |
| Bydureon | 68 | under 0.1% |
| Exenatide (generic) | 53 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Virginia Employee Plan and Insurer GLP-1 Rules
Commonwealth of Virginia state employee health plan
Covers with limitsVirginia's state employee health plans require a BMI of 35 or higher, plus prior authorization, for a weight-loss GLP-1 under the criteria announced for the 2026 open enrollment.
The Department of Human Resource Management's 2026 open enrollment guide sets a BMI of 35 or higher.
“A Body Mass Index (BMI) of 35 or higher is required to obtain a weight loss GLP-1 medication.”
Source: Virginia Department of Human Resource Management. Read October 29, 2026.
We have no Virginiainsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.
Comparing self-pay programs in Virginia?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Virginia
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Virginia. The rest record a state count without naming the states, so confirm Virginia with the program at intake before you pay.
What Programs' Own Pages Say About Virginia
8 of the 8 programs whose own pages name the states they serve include Virginia: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Virginia |
|---|---|
| Willow | Serves VA |
| SnagRx | Serves VA |
| Strut Health | Ships to VA |
| MangoRx | Ships to VA |
| Wellorithm | Serves VA |
| MEDGm | Serves VA |
| TelosRx | Serves VA |
| Trimi | Serves VA |
Trimi's state table lists Virginia as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Virginia is Va. Code § 54.1-3303(B). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Virginia
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Virginia, 2024
Virginia prescribers wrote 443,694 Medicare Part D GLP-1 claims in 2024, number 18 of 51, with $569.8 million in gross drug cost before rebates. Ozempic led with 202,349 claims for 41,109 enrollees. Wegovy had 5,489 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | VA Part D claims | Enrollees |
|---|---|---|
| Ozempic | 202,349 | 41,109 |
| Trulicity | 117,120 | 21,718 |
| Mounjaro | 81,396 | 15,416 |
| Rybelsus | 24,416 | 6,534 |
| Victoza | 7,143 | Not given |
| Wegovy | 5,489 | 1,414 |
| Bydureon Bcise | 3,626 | 753 |
| Liraglutide | 1,920 | 766 |
| Byetta | 235 | 67 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Virginia
The Bridge is national, so the rules are the same in Virginia as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Virginia Compares to Other Mid-Atlantic States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Virginia and its neighbors in the Mid-Atlantic are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Virginia (this page) | Covered, January 2026 (KFF) | 227,472 |
| Delaware | Covered, January 2026 (KFF) | 55,674 |
| District of Columbia | Not covered | 27,754 |
| Maryland | Not covered | 148,487 |
| West Virginia | Not covered | 94,999 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for Virginia Cities
If Your Insurance Denies GLP-1 Coverage in Virginia
Commercial plans offer an internal appeal, then external review; Virginia Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Virginia
- Virginia Medicaid: Medicaid: covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: Commonwealth of Virginia state employee health plan, covers with limits per the documents cited above. Confirm with the plan before you fill a prescription.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Virginia
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Virginia.
Frequently Asked Questions — Virginia
Does Virginia Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Virginia Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Virginia in 2024?
Does the Virginia state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Virginia?
Which online GLP-1 programs serve Virginia?
Does Medicare cover GLP-1s in Virginia?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.